Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
47 Cards in this Set
- Front
- Back
What type of virus is HIV?
|
Retroviridae - enveloped RNA
|
|
What is the replicative strategy of HIV?
|
Reverse transcriptase makes copies of viral DNA from viral RNA, then a complementary strand is made giving viral dsDNA, then this is entered into host chromosomes and host cell RNA polymerases make mRNA from viral dsDNA
|
|
Why does HIV mutate so much?
|
Reverse transcriptase does not have proofreading capability, so replicates quickly but with errors that are not corrected
|
|
What are some complications of the high mutation rate of HIV?
|
HIV mutates at a rate of one nucleotide per day, which makes it hard to create a vaccine or use antivirals (resistance can develop quickly)
|
|
What are the three key HIV genes?
Where do the HIV medications work? |
gag, pol, env
medications work at pol |
|
What molecules are critical to HIV attachment to CD4 cells?
|
CCR5
CXCR4 (on host cell) |
|
Which HIV predominates in early infection?
In late infection? |
M-tropic which bind to CD4/CCR5 cells early in infection (macrophages, dendritic cells, some T cells)
T-tropic which binds to CD4/CXCR4 cells late in infection (to naive or helper T cells) |
|
What is the sequence of HIV binding to a cell?
|
gp120 on HIV binds to CD4, then conformational change, then gp120-CD4 binds to CCR5, then gp41 penetrates the membrane and the two membranes fuse and dump in RNA material
|
|
What does integrase do?
|
Splices HIV into the host genome
|
|
What does protease do?
|
Cleaves viral polyproteins during viral release from cell, rendering an infectious virion
|
|
What are the divisions of HIV?
|
2 types (HIV-1 and HIV-2)
HIV-1 has M, O, and N types Within M there are clades A-J |
|
What is the most common type of HIV?
|
HIV-1 M, clade B
|
|
What parts of the body are clades C and E more likely to infect?
What parts of the world have this strain most? |
Vaginal mucosa, cervix, foreskin of penis (found in heterosexually-spread)
Asia and Africa |
|
What are some differences between HIV-1 and HIV-2?
|
HIV-2 is less infectious and has slower disease progression
|
|
How is HIV-2 often treated?
|
With protease inhibitors (have intrinsic resistance to NNRTIs)
|
|
How do most males get HIV in the US? Most females?
|
Males through MSM, females through high-risk heterosexual contact
|
|
Is it easier to get HIV from male-->female or female-->male?
|
male-->female (volume of fluid and amount of mucosa exposed)
|
|
What is the method of transmission most likely to spread HIV to the recipient?
|
Blood transfusion or organ transplant
|
|
How many infections per 100 exposures will result in HIV from a needle stick?
|
0.3
|
|
How many days after exposure will an antibody assay be able to identify HIV infection?
|
about 21 days (3-4 weeks usually)
|
|
What diagnostic test is used to confirm an ELISA?
|
Western blot
|
|
What test cannot be used to diagnose HIV?
Why? |
CD4 count
It can be affected by a lot of different factors such as stress, steroids, illness) |
|
What are the two factors important in disease progression?
|
CD4 count
Viral load |
|
What are some indications of HIV therapy?
|
Nephropathy
Hep B CD4 <350 (recently changed to 500) Pregnancy Post-Exposure Prophylaxis AIDS-defining illness NOT VIRAL LOAD |
|
Why is viral load not an indicator for HIV therapy?
|
Cannot predict rate of CD4 cell count decline using HIV-1 RNA level
|
|
How do NRTIs work?
What is the class side effect? |
Stops chain growth of viral DNA from viral RNA (which is done by RT)
Can cause lactic acidosis |
|
What class is abacavir in? What is the side effect of it?
|
NRTI
Causes hypersensitivity (rash in 2/3 along with fever, fatigue, GI distress, cough, pharyngitis) due to HLA-B*5701 |
|
What is the most-commonly used NNRTI?
|
Efavirenz
|
|
What are two downsides to the use of efavirenz?
|
Cannot give during pregnancy
Gives very vivid sexual dreams during the first month |
|
What is the mechanism of action of NNRTIs?
|
Bind directly to reverse transcriptase so it cannot add new nucleotides to viral DNA strand
|
|
What are the class side effects of NNRTIs?
|
Rash
|
|
What is the biggest downfall to using NNRTIs?
|
Class resistance - if lose resistance to one, lose it to all
|
|
What are two advantages of using NNRTIs?
|
Low pill burden and only take once daily - compliance is easy
|
|
What are the class side effects of protease inhibitors?
|
Drug interactions and dyslipidemia
|
|
What is the main side effect of the protease inhibitor indinavir?
|
Kidney stones (look for R flank pain or blood in urine as warning signs)
|
|
What are the two most commonly used protease inhibitors?
Side effects? |
Fosamprenavir - parasthesias
Atazanavir - increased indirect bilirubin |
|
What is the mechanism of action of fusion inhibitors?
|
Prevents the virus from attaching to the CD4 cell
|
|
In combination HIV medications what kinds of combinations are used?
|
2 NRTIs and NNRTI
2 NRTIs and PI NRTI and NNRTI and PI Atripla common (efavirenz the NNRTI and FTC and TDF, the NRTIs) |
|
What is the first type of resistance test done? What is next?
|
Genotype, then phenotype or virtual phenotype
|
|
What are the symptoms of acute retroviral syndrome?
What are people with this often diagnosed with? |
Nonspecific mild symptoms like fever, adenopathy, pharyngitis, maculopapular rash, myalgia
EBV Mononucleosis (except rash is often also found in mouth, genitals) |
|
What tests should be used to confirm acute retroviral infection?
|
HIV viral load (RNA, confirmed with serological testing)
|
|
What are some potential complications of HIV treatment?
|
Inflammatory syndrome/flare (CMV infection)
Worsening of previously-stable viral hepatitis Treat with NSAIDS, steroids, need to determine whether bad enough to discontinue HIV meds |
|
What is the needlestick rule of 3?
|
Chances of coming down with these infections due to a needlestick:
~HBV (30%) ~HCV (3%) ~HIV (0.3%) |
|
When should PEP be considered, what does it involve?
|
Percutaneous exposure is 0.3%, mucous membrane exposure is 0.09%, not a risk if exposure is through intact skin
Treat within a few hours and for 4 weeks - check HIV at baseline, 3mo, and 6mo |
|
What is the mother-to-child transmission rate when triple drugs are being used (besides atripla)?
|
1.2%
If viral load is over 1000c/mL, consider a C-section |
|
What opportunistic infection has the broadest range of CD4 levels it will attack at?
|
TB
|
|
What is used to for primary prophylaxis for PCP when CD4 is under 200 and Toxoplasma when CD4 is under 100?
|
Bactrim
|